PHIO PHARMACEUTICALS CORP.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $13.0M | $17.0M | $21.0M | $10.7M | $10.8M | $13.3M | $5.4M | $5.4M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $14.3M | $17.4M | $21.5M | $11.5M | $11.3M | $13.4M | $5.7M | $5.9M |
| Property, Plant & Equipment | $9.0K | $10.0K | $11.0K | $12.0K | $7.0K | $4.0K | $2.0K | $1.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $14.3M | $17.4M | $21.5M | $11.5M | $11.3M | $13.4M | $5.7M | $5.9M |
| Liabilities | ||||||||
| Accounts Payable | $901.0K | $260.0K | $435.0K | $516.0K | $235.0K | $427.0K | $253.0K | $184.0K |
| Total Current Liabilities | — | — | — | — | $1.2M | $1.3M | $1.0M | $919.0K |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $1.7M | $950.0K | $1.3M | $1.7M | $1.2M | $1.3M | $1.0M | $919.0K |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-163.2M | $-159.1M | $-155.1M | $-152.7M | $-150.3M | $-148.1M | $-146.4M | $-144.7M |
| Total Stockholders' Equity | $12.6M | $16.5M | $20.1M | $9.8M | $10.1M | $12.2M | $4.7M | $4.9M |